AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreisek, G.
Right arrow Articles by Weishaupt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreisek, G.
Right arrow Articles by Weishaupt, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.06.0719
AJR 2007; 188:1081-1088
© American Roentgen Ray Society


Original Research

MR Arthrography of the Shoulder, Hip, and Wrist: Evaluation of Contrast Dynamics and Image Quality with Increasing Injection-to-Imaging Time

Gustav Andreisek1, Sylvain R. Duc2, Johannes M. Froehlich3, Juerg Hodler2 and Dominik Weishaupt1

1 Institute for Diagnostic Radiology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
2 Department of Radiology, Orthopedic University Hospital Balgrist, Zurich, Switzerland.
3 Guerbet AG, Zurich, Switzerland.

Received May 29, 2006; accepted after revision August 31, 2006.

 
Address correspondence to D. Weishaupt (dominik.weishaupt{at}usz.ch).


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of our study was to investigate the contrast dynamics and the relationship between visualization of intraarticular structures and time elapsed between intraarticular injection of contrast agent and MRI in symptomatic patients referred for MR arthrography of the shoulder, hip, and wrist.

SUBJECTS AND METHODS. Our local ethics committees and the national drug administration approved this multicentric study. We prospectively studied 11 shoulders, 11 hips, and 10 wrists. After the intraarticular gadolinium injection, patients underwent a baseline MR arthrography protocol (time point [TP] 1) and subsequent MRI at another four time points (TP 2-TP 5) up to 240 minutes. The course of contrast-to-noise ratio (CNR) over time was calculated. Three observers assessed the degree of visualization of different intraarticular structures and the overall image quality at each time point using a 3-point scale and a 5-point scale, respectively.

RESULTS. For all joints, CNR measurements showed peak CNR at TP 1 (21 minutes) and TP 2 (45 minutes) with a subsequent, near-logarithmic decline of CNR values over time. Visualization of different anatomic structures decreased over time. Overall image quality was insufficient for diagnostic purposes at TP 3 (96 minutes) in three (27%) of 11 shoulders and in three (27%) of 11 hips. In two (20%) of 10 wrists, image quality was insufficient at TP 2 (45 minutes).

CONCLUSION. For MR arthrography, the degree of visualization of intraarticular structures depends on the time elapsed between contrast injection and MRI. MR arthrography of the shoulder and hip should be performed within 90 minutes, and MR arthrography of the wrist should be performed within 45 minutes, after intraarticular injection.

Keywords: arthrography • hip • MR • musculoskeletal imaging • shoulder • wrist


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
MR arthrography with intraarticular injection of gadolinium-based contrast agents (also called "direct MR arthrography") is increasingly being used to evaluate joint disorders. The contrast medium injected for MR arthrography separates the articular capsule from other structures and, due to considerable T1 shortening, outlines intraarticular structures on T1-weighted images [1]. Direct MR arthrography has been successfully used in many joints of the body for a variety of conditions. Compared with standard MRI, MR arthrography improves the detection of loose bodies and osteochondral lesions in any of the large peripheral joints. Moreover, direct MR arthrography improves the assessment of internal joint derangements, such as the detection of labral and ligamentous abnormalities in the shoulder and hip. In the wrist, MR arthrography improves confidence in the diagnosis of interosseous ligament tears and tears of the triangular fibrocartilage complex [1-7].

Intraarticular injection of gadolinium-based contrast agents is considered to be a safe procedure [8]. The prevalence of joint infection rates after arthrography is reported to be 0.003% [9]. Although the technique of direct MR arthrography is increasingly used by radiologists, there is little in the literature regarding the temporal behavior of the injected gadolinium compound. Apart from experimental results in animals [10, 11], only a few studies have addressed the kinetics of the intraarticularly injected gadolinium [12-14]. To our knowledge, only one study has evaluated the time behavior of an intraarticularly injected gadolinium compound in humans. In the study by Wagner et al. [14], the temporal behavior of intraarticularly administered gadolinium was evaluated over time in four shoulders, four knees, and four hips of human volunteers after direct MR arthrography.

In this study we sought to assess the temporal behavior of an intraarticular gadoliniumbased contrast agent in the shoulder, hip, and wrist in symptomatic patients. MR arthrograms obtained at different time points after gadolinium injection were assessed not only with regard to quantitative parameters but also with regard to the degree of visibility of various anatomic structures at each time point.

The purpose of this study was to prospectively investigate the contrast dynamics over time and the relationship between the visualization of intraarticular structures and the time elapsed between the intraarticular injection of the contrast agent and MRI in symptomatic patients.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Our local ethics committees and the national drug administration approved this prospective multicentric study that was performed at two radiology institutions. Written informed consent was obtained from all patients. The intraarticular administration of gadolinium (2.5 mmol/L of gadoterate meglumine, gadoteric acid, Artirem, Guerbet,) is licensed by the responsible national drug administration.

Patients
During an 8-month period (February to September 2005), a total of 973 direct MR arthrographic examinations of the shoulder, 136 direct MR arthrographic examinations of the wrist, and 343 direct MR arthrographic examinations of the hip were performed at the two institutions involved in this study.

Patients were included in the study only if there was a clinical indication for MR arthrography and if the patients were willing to participate in the study protocol, which consisted of the routine protocol of direct MR arthrography (baseline examination) and subsequent MR examinations at different time points (see following text). To homogenize the study population, only those patients with suspected internal derangements of the shoulder, hip, or wrist joint were included in whom synovial hypertrophy or synovitis was not expected. Patients with inflammatory rheumatologic disorders or with suspected septic arthritis were excluded.

From these 1,452 patients who were considered eligible for the study, we included consecutively 11 patients who were scheduled for direct MR arthrography of the shoulder, 11 patients who were scheduled for direct MR arthrography of the hip, and 10 patients who were scheduled for direct MR arthrography of the wrist (19 men, 13 women; mean age, 36 years; age range, 18-64 years).

MR Protocol
After intraarticular injection of the contrast agent under fluoroscopic guidance, all patients underwent MRI according to the routine MR arthrographic protocol for each joint. The MR protocol started with a fat-suppressed and a non-fat-suppressed T1-weighted spin-echo sequence in all joints. After these two sequences (time point [TP] 1, 20 minutes), the other sequences of the individual MR arthrographic protocol were performed. After acquiring all the sequences of the routine protocol, another pair consisting of a fat-suppressed and a non-fat-suppressed T1-weighted spin-echo sequence was obtained (TP 2, 45 minutes). Another three pairs of fat-suppressed and a non-fat-suppressed T1-weighted spin-echo sequences were repeated 90 minutes (TP 3), 180 minutes (TP 4), and 240 minutes (TP 5) after the intraarticular injection of the contrast agent. The sequence parameters are displayed in Table 1. Sequences were oriented in the transverse plane for the shoulder and in the coronal plane for the hip and wrist. Sequence parameters were unchanged throughout each consecutive pair of T1-weighted spin-echo sequences.


View this table:
[in this window]
[in a new window]

 
TABLE 1: Parameters for TI-Weighted Spin-Echo MRI With and Without Fat Suppression After Intraarticular Gadolinium Injection

 

In addition to these sequences, our routine protocols for MR arthrography examination at baseline (between TP 1 and TP 2) of the shoulder, hip, and wrist included standard T2-weighted fast spin-echo sequences and STIR or proton density-weighted sequences in the sagittal, coronal, and transverse planes. In the hip, fast imaging sequences using steady-state precession (true fast imaging with steady-state free precession [FISP] or steady-state free precession [SSFP]) were also performed. However, not all these sequences were used for image analysis in our study.

MRI was performed using one of three 1.5-T scanners (Avanto or Symphony, Siemens Medical Solutions; or Signa Excite HD, GE Healthcare). For MR arthrography of the shoulder, a dedicated shoulder array coil was used. Similarly, for MR arthrography of the wrist, dedicated 4-channel high-resolution wrist coils were used. For MR arthrography of the hip, an 8-channel phased-array torso-pelvic coil or a flexible surface coil (total imaging matrix, TIM) was used.

Intraarticular Contrast Injection
Intraarticular injections were performed under fluoroscopic guidance using aseptic technique. In each case, 1 mL of mepivacaine (Scandicain 2%, AstraZeneca) was administered before the insertion of a 19-gauge needle (hip, shoulder) or 23-gauge needle (wrist) into the joint space. The intraarticular injection protocol, including the volume of the intraarticularly injected contrast agent, was similar to those reported in the literature for shoulder [13, 15, 16], hip [16], and wrist [1] MR arthrography.

For shoulder and hip joints, a maximum of 1 mL of an iodinated contrast agent (200 mg I/mL of iopamidol, Iopamiro 200, Bracco Diagnostics; or 200 mg I/mL of sodium and ioxaglate meglumine, Hexabrix 200, Guerbet) was administered for control of correct needle placement. Intraarticular injection was performed using an anterosuperior approach to the joint space with a total of 12 mL of gadoterate meglumine (0.0025 mmol/mL of gadolinium with an osmolality of 285 mosm/kg of H2O [Artirem], Guerbet) for the shoulder joint and 10 mL of gadoterate meglumine for the hip joint. In the wrist, a doublecompartment injection technique was used (distal radioulnar and midcarpal compartments) with a minimal amount of iodinated contrast agent. A maximum of 1 mL of gadoterate meglumine was injected into the distal radioulnar joint and 3-4 mL into the midcarpal compartment. The injection was stopped when fluoroscopic images showed sufficient distention of the individual joint compartment.

In all patients, care was taken not to introduce air into the joint, and any joint effusion was aspirated before instilling the contrast material. Epinephrine was not used to avoid any influence on the temporal behavior of the gadolinium-based contrast agent. All patients tolerated the procedure well with no adverse reactions or complications related to the intraarticular injection.

All patients were asked to avoid active motion of the joint between the intraarticular injection of the contrast material and baseline MRI and between baseline MRI and the subsequent MR examinations at different time points.

Image Analysis
Quantitative image analysis—Signal intensity was assessed by measuring regions of interest (ROIs) in the joint space (intraarticular fluid) and in the adjacent muscle tissue (shoulder, deltoid muscle; hip, iliopsoas muscle; wrist, pronator quadratus muscle) at each time point on both non-fat-suppressed and fat-suppressed images (image sets). Signal intensity of the intraarticular fluid was measured in the axillary recess of the shoulder adjacent to the articular surface of the humeral head [14], in the recess of the hip [14], and in the recess of the distal radioulnar joint or adjacent to the radial styloid in the radiocarpal joint space of the wrist [17]. ROIs were placed at the identical locations on each image set. Moreover, to avoid volume artifacts (e.g., in late image sets), placement of the ROIs was repeated three times, and calculation of contrast-to-noise ratio (CNR) was averaged on the basis of these measurements of signal intensity. The circular ROI measured 5-10 mm2 for the shoulder, 3-8 mm2 for the hip, and 1-5 mm2 for the wrist. SD of the background noise was computed for all sequences. For comparison purposes, CNR of the intraarticular signal was calculated using the following equation [13]:

Formula

Qualitative image analysis—Three experienced musculoskeletal radiologists, blinded to all clinical and radiologic data, evaluated all MR images in random order, first independently and then in consensus. Randomization was performed with regard to patients and the different time points and with regard to fat-suppressed versus non-fat-suppressed MR images. Three separate interpretation sessions for shoulder, hip, and wrist MR arthrograms were performed. MR images were evaluated on a dedicated PACS workstation using commercially available PACS software (I-SoftView, version 5.2, Cedara Software).

All image sets (i.e., non-fat-suppressed and fatsuppressed images of each joint) were analyzed with regard to three visual aspects: joint distention, sharpness of joint borders, and contrast between intraarticular fluid and surrounding structures. Each of these aspects was scored as poor, fair, or good. The exact definitions of the scores and their adaptation for each joint are presented in Table 2. Presence and cause of artifacts (e.g., air, motion, inhomogeneous fat suppression, and infolding or susceptibility artifacts) were noted.


View this table:
[in this window]
[in a new window]

 
TABLE 2: Criteria for Image Quality After Intraarticular Gadolinium Injection in the Shoulder, Hip, and Wrist

 

In addition, overall image quality was assessed. Overall image quality reflected a general impression of each image set with regard to the use for diagnostic purposes. A 5-point scale (1-5) was used. A score of 5 meant excellent image quality (perfect contrast between relevant structures, well-delineated borders, no artifacts), and a score of 1 meant inferior image quality (insufficient contrast between the joint and surrounding structures, severe blurring, or severe artifacts) [7]. A cutoff value of 3 was defined for the differentiation between sufficient and insufficient quality. We assumed that at least 90% of all image sets should be of sufficient quality (score value ≥ 3) to render a specific time point clinically useful.

Statistical Analysis
Before this study, sample size estimation was performed. A sample size of 32 patients was considered to be comparable to other pharmacokinetic studies [18-20] and to other studies with regard to the temporal behavior of intraarticularly administered gadolinium-based contrast agents [14]. Data are presented in a descriptive fashion by reporting the original raw data in absolute and relative numbers and by using graphical and pictorial formats. CNR values at each time point are summarized by using clustered box plots to show the structure of the original raw data (e.g., the median, quartiles, and extreme values) and the decline of the CNR values over time. Data regarding overall image quality in the shoulder, hip, and wrist are presented as means of the overall image quality at each time point. For all computations, SPSS software was used (release 12.0.1, SPSS).


Figure 1
View larger version (11K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —Decrease of contrast-to-noise ratio (CNR) over time. Clustered box plots show temporal behavior in hip (light gray), shoulder (dark gray), and wrist (white) with regard to T1-weighted spin-echo imaging without (A) and with (B) fat suppression.

 


Figure 2
View larger version (11K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —Decrease of contrast-to-noise ratio (CNR) over time. Clustered box plots show temporal behavior in hip (light gray), shoulder (dark gray), and wrist (white) with regard to T1-weighted spin-echo imaging without (A) and with (B) fat suppression.

 

Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
A total of 320 image sets were evaluated (32 patients x 5 time points x 2 spin-echo sequences). Baseline MRI (TP 1) was performed with a mean delay of 21 minutes after intraarticular injection (range, 11-28 minutes). Forty-five minutes after the injection, MRI at TP 2 was performed (range, 28-61 minutes). MRI was repeated again after a mean delay of 96 minutes (TP 3; range, 66-126 minutes), 158 minutes (TP 4; range, 128-181 minutes), and 217 minutes (TP 5; range, 183-247 minutes) after intraarticular injection of the contrast agent.

Quantitative Analysis
Figure 1A, 1B shows the CNR values obtained in the shoulder, hip, and wrist at each time point on T1-weighted spin-echo images with and without fat suppression. Box plots showed similar trends with decreasing CNR over time for each joint. The peak median CNR was observed at TP 1 in most joints and image sets, followed by a near-logarithmic decline of CNR values during follow-up. Minimum CNR values showed a trend toward 0 over time (no contrast could be measured between the joint fluid and the surrounding muscle tissue). Absolute CNR values were slightly higher with fat suppression when compared with images sets without fat suppression.

Qualitative Image Analysis
Table 3 gives an overview of the frequency distribution of the different quality ratings. There were a decreasing number of good or fair ratings over time for each of the visual aspects (joint distention, sharpness of anatomic structures, and contrast between two adjacent anatomic structures).


View this table:
[in this window]
[in a new window]

 
TABLE 3: Overview of Frequency Distribution of Image Quality Score with Regard to Different Criteria and Different Joints

 

Artifacts were observed in 24 (7.5%) of 320 image sets. Minor motion artifacts were present in 10 image sets, infolding and ringing artifacts occurred in five image sets, and small air bubbles in the joint fluid were detected in nine image sets. None of these 24 image sets was considered to be of insufficient image quality due to the observed artifact.

Figure 2A, 2B, 2C shows the mean overall image quality for direct MR arthrography. Both image sets (with and without fat suppression) showed similar trends, with a decrease of the overall image quality over time. Spin-echo imaging with fat suppression was consistently superior to spinecho imaging without fat suppression (Fig. 3A, 3B).


Figure 3
View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A —Overall image quality for direct MR arthrography using T1-weighted spin-echo MRI with (black) and without (gray) fat suppression. Bars represent mean overall image quality using 5-point scale. Figures show similar trends in decreasing image quality over time for imaging shoulder (A), hip (B), and wrist (C).

 

Figure 4
View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B —Overall image quality for direct MR arthrography using T1-weighted spin-echo MRI with (black) and without (gray) fat suppression. Bars represent mean overall image quality using 5-point scale. Figures show similar trends in decreasing image quality over time for imaging shoulder (A), hip (B), and wrist (C).

 

Figure 5
View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C —Overall image quality for direct MR arthrography using T1-weighted spin-echo MRI with (black) and without (gray) fat suppression. Bars represent mean overall image quality using 5-point scale. Figures show similar trends in decreasing image quality over time for imaging shoulder (A), hip (B), and wrist (C).

 

Figure 6
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —36-year-old man with chronic left-sided wrist pain. Coronal T1-weighted spin-echo sequences (TR/TE, 420/15) with (A) and without (B) fat suppression acquired 19 minutes after intraarticular injection of Gd-DOTA (tetraazacyclododecanetetraacetic acid) (time point 1). In distal radioulnar joint (arrow), joint distension, sharpness of anatomic structures, and contrast between joint fluid and adjacent anatomic structures was rated higher on fat-suppressed MR images (good) than on non-fat-suppressed images (fair).

 

Figure 7
View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —36-year-old man with chronic left-sided wrist pain. Coronal T1-weighted spin-echo sequences (TR/TE, 420/15) with (A) and without (B) fat suppression acquired 19 minutes after intraarticular injection of Gd-DOTA (tetraazacyclododecanetetraacetic acid) (time point 1). In distal radioulnar joint (arrow), joint distension, sharpness of anatomic structures, and contrast between joint fluid and adjacent anatomic structures was rated higher on fat-suppressed MR images (good) than on non-fat-suppressed images (fair).

 
At TPs 1 and 2, the overall image quality of all 11 MR arthrographic examinations of the shoulder (100%) was rated ≥ 3 for both the fatsuppressed and the non-fat-suppressed sequences. This percentage decreased over time (at TP 3, 8/10 [80%] fat-suppressed sequences and 4/10 [40%] non-fat-suppressed sequences; at TP 4, 4/8 [50%] fat-suppressed sequences and 1/8 [13%] non-fat-suppressed sequences; and at TP 5, 3/7 [43%] fat-suppressed sequences and 0/7 [0%] non-fat-suppressed sequences). In the hip, overall image quality was rated ≥ 3 in 10/11 (90%) MR arthrographies at TP 1 for both fat-suppressed and non-fat-suppressed sequences (at TP 2, 9/10 [90%, fat-suppressed] and 9/10 [90%, non-fat-suppressed]; at TP 3, 7/10 [70%] and 6/10 [60%]; at TP 4, 5/10 [50%] and 4/10 [40%]; and at TP 5, 1/9 [11%] and 1/9 [11%]) (Fig. 4A, 4B, 4C, 4D, 4E). Corresponding results for image quality of the wrist were as follows: TP 1, 9/10 (90%, fat suppressed) and 8/10 (80%, non-fat-suppressed); TP 2, 8/10 (80%) and 5/10 (50%); TP 3, 8/10 (80%) and 4/10 (40%); TP 4, 7/10 (70%) and 1/10 (10%); and TP 5, 3/10 (30%) and 1/10 (10%).


Figure 8
View larger version (154K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A —28-year-old man with chronic right-sided hip pain. A Coronal fat-suppressed T1-weighted spin-echo sequences (TR/TE, 500/13) were acquired at 17 minutes (time point [TP] 1) (A), 50 minutes (TP 2) (B), 115 minutes (TP 3) (C), 175 minutes (TP 4) (D), and 217 minutes (TP 5) (E) after intraarticular administration of Gd-DOTA (tetraazacyclododecanetetraacetic acid). MR image acquired at TP 1 (A) shows maximal distension of hip recess (arrow) and maximal sharpness of labrum, as well as maximal contrast between joint fluid versus labrum and cartilage. MR image at TP 2 (B) still shows good distension, sharpness, and contrast (arrow). At TP 3 (C), MR image shows notable loss of joint distension, sharpness, and contrast between intraarticular structures (arrow). At TPs 4 (D) and 5 (E), image quality was rated insufficient for diagnostic purposes because of lack of joint distension and contrast (arrows).

 

Figure 9
View larger version (148K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B —28-year-old man with chronic right-sided hip pain. Coronal fat-suppressed T1-weighted spin-echo sequences (TR/TE, 500/13) were acquired at 17 minutes (time point [TP] 1) (A), 50 minutes (TP 2) (B), 115 minutes (TP 3) (C), 175 minutes (TP 4) (D), and 217 minutes (TP 5) (E) after intraarticular administration of Gd-DOTA (tetraazacyclododecanetetraacetic acid). MR image acquired at TP 1 (A) shows maximal distension of hip recess (arrow) and maximal sharpness of labrum, as well as maximal contrast between joint fluid versus labrum and cartilage. MR image at TP 2 (B) still shows good distension, sharpness, and contrast (arrow). At TP 3 (C), MR image shows notable loss of joint distension, sharpness, and contrast between intraarticular structures (arrow). At TPs 4 (D) and 5 (E), image quality was rated insufficient for diagnostic purposes because of lack of joint distension and contrast (arrows).

 

Figure 10
View larger version (146K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C —28-year-old man with chronic right-sided hip pain. Coronal fat-suppressed T1-weighted spin-echo sequences (TR/TE, 500/13) were acquired at 17 minutes (time point [TP] 1) (A), 50 minutes (TP 2) (B), 115 minutes (TP 3) (C), 175 minutes (TP 4) (D), and 217 minutes (TP 5) (E) after intraarticular administration of Gd-DOTA (tetraazacyclododecanetetraacetic acid). MR image acquired at TP 1 (A) shows maximal distension of hip recess (arrow) and maximal sharpness of labrum, as well as maximal contrast between joint fluid versus labrum and cartilage. MR image at TP 2 (B) still shows good distension, sharpness, and contrast (arrow). At TP 3 (C), MR image shows notable loss of joint distension, sharpness, and contrast between intraarticular structures (arrow). At TPs 4 (D) and 5 (E), image quality was rated insufficient for diagnostic purposes because of lack of joint distension and contrast (arrows).

 

Figure 11
View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4D —28-year-old man with chronic right-sided hip pain. Coronal fat-suppressed T1-weighted spin-echo sequences (TR/TE, 500/13) were acquired at 17 minutes (time point [TP] 1) (A), 50 minutes (TP 2) (B), 115 minutes (TP 3) (C), 175 minutes (TP 4) (D), and 217 minutes (TP 5) (E) after intraarticular administration of Gd-DOTA (tetraazacyclododecanetetraacetic acid). MR image acquired at TP 1 (A) shows maximal distension of hip recess (arrow) and maximal sharpness of labrum, as well as maximal contrast between joint fluid versus labrum and cartilage. MR image at TP 2 (B) still shows good distension, sharpness, and contrast (arrow). At TP 3 (C), MR image shows notable loss of joint distension, sharpness, and contrast between intraarticular structures (arrow). At TPs 4 (D) and 5 (E), image quality was rated insufficient for diagnostic purposes because of lack of joint distension and contrast (arrows).

 

Figure 12
View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4E —28-year-old man with chronic right-sided hip pain. Coronal fat-suppressed T1-weighted spin-echo sequences (TR/TE, 500/13) were acquired at 17 minutes (time point [TP] 1) (A), 50 minutes (TP 2) (B), 115 minutes (TP 3) (C), 175 minutes (TP 4) (D), and 217 minutes (TP 5) (E) after intraarticular administration of Gd-DOTA (tetraazacyclododecanetetraacetic acid). MR image acquired at TP 1 (A) shows maximal distension of hip recess (arrow) and maximal sharpness of labrum, as well as maximal contrast between joint fluid versus labrum and cartilage. MR image at TP 2 (B) still shows good distension, sharpness, and contrast (arrow). At TP 3 (C), MR image shows notable loss of joint distension, sharpness, and contrast between intraarticular structures (arrow). At TPs 4 (D) and 5 (E), image quality was rated insufficient for diagnostic purposes because of lack of joint distension and contrast (arrows).

 

Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Direct MR arthrography extends the capabilities of standard MRI by distending the joint and improving tissue contrast. When performing MR arthrography, delineation of complex anatomic structures and visualization of subtle abnormalities may be improved [1, 4]. Although direct MR arthrography is increasingly used by radiologists and the technique is considered to be safe [8], there is a paucity of data regarding the temporal behavior of the intraarticularly administrated gadolinium chelate. When gadolinium chelates are administrated intraarticularly, the contrast material is eliminated from the joint over time by transsynovial diffusion [14, 21-23]. The specific mechanism of the transsynovial diffusion of gadolinium is complex and influenced by various factors, including the permeability, vascularity, and surface area of the synovial membrane; the volume of articular fluid; the concentration gradient of plasma and contrast-enhanced joint fluid; and intraarticular pressure [24-27].

From a practical point of view, knowledge of temporal behavior is important because the amount of fluid in the joint and the signal characteristics of the injected contrast agent determine the quality of an MR arthrogram.

Kopka et al. [13] investigated the relationship between MRI and the time point of the contrast injection. In a prospective study, Wagner et al. [14] performed MR examinations of four shoulder, hip, and knee joints in healthy volunteers at various time points after intraarticular injection of gadopentetate dimeglumine using standard doses. CNR measurements were performed. The maximum CNR decrease (53%) occurred 1 hour after intraarticular gadolinium injections in the shoulder, whereas the maximum CNR decrease occurred 2 hours after injection in the hip joint. In the knee joint, the maximum CNR decrease (86%) was found between 3.5 and 6.25 hours.

Using spectrometric methods, Hajek et al. [11] measured residual quantities of gadolinium in the cartilage and synovium after MR arthrography with gadopentetate dimeglumine in an animal model. It was shown that gadopentetate dimeglumine is resorbed by the synovium within a few hours. Using histologic sections of human joint cartilage, Engel [28] showed that, 14 hours after the intraarticular administration of gadolinium, no measurable traces of gadopentetate dimeglumine could be established in the specimen.

In our study, we showed a near-logarithmic decrease of the CNR within the first 45-90 minutes for all evaluated joints. The decline of the CNR is reflected by a visual decrease in the image quality. The image quality for diagnostic purpose becomes critical 45 minutes after contrast injection for the wrist joint and after 90 minutes for the shoulder and hip joints. With regard to our statement that at least 90% of all image sets at a specific time point should be sufficient for diagnostic purposes, MRI of the wrist joint should be performed within 45 minutes, and MRI of the shoulder and hip joints should be performed within 90 minutes, after intraarticular contrast injection.

To our knowledge, the influence of using a fat-suppression technique on the image quality at different time points has not been systematically evaluated for MR arthrography. At each time point, we obtained a pair of a fat-suppressed and a non-fat-suppressed T1-weighted spin-echo sequences. We noted similar results for the different quality ratings and for the temporal behavior of CNR for fat-suppressed and for non-fat-suppressed MRI. However, fat-suppressed spin-echo sequences are more sustainable in longer delays between the injection and the MRI than are non-fatsuppressed spin-echo sequences.

Our study contributes to the optimization of patient scheduling for direct MR arthrography. Because patients usually must be transferred from the fluoroscopy suite to the MR imager after the intraarticular injection, image quality of MR arthrograms may be insufficient if the time delay between the injection and T1-weighted MRI is too long.

We acknowledge several limitations of our study. One limitation may be that we did not include patients with inflammatory rheumatologic disorders. Because of the expected synovial hyperperfusion in patients with inflammatory rheumatology disorders, the diffusion of the intraarticularly administrated gadolinium chelate in MR arthrography may even be faster, resulting in a shorter time window during which MRI should be performed. On the other hand, direct MR arthrography is not typically performed in inflammatory disease. IV contrast injection may be superior by showing the hypertrophic synovial membrane.

Our study could also be criticized in that we evaluated only the temporal behavior of the signal characteristics on non-fat-suppressed or fat-suppressed spin-echo sequences. However, conventional T1-weighted spin-echo or fast spin-echo sequences are still considered the most useful sequences for MR arthrography, particularly when the T1 effect of the injected contrast agent is taken into consideration [1, 16]. Other studies have suggested the use of steady-state free precision sequences and other gradient-echo sequences for imaging internal joint disorders [29, 30]. Finally, we did not rate the value of the individual image sets obtained at different time points for potential differences in making a final diagnosis. However, because at the different time points only one type of sequence—that is, spin-echo sequences—and only one imaging plane were available, such an imaging analysis was not possible.

In conclusion, for MR arthrography, visualization of intraarticular anatomic structures depends on the time elapsed between the contrast injection and MRI. For MR arthrography of the shoulder and hip, MRI should be performed within 1.5 hours after contrast injection, and MR arthrography of the wrist should be performed within 45 minutes.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Steinbach LS, Palmer WE, Schweitzer ME. Special focus session: MR arthrography. RadioGraphics 2002;22 : 1223-1246[Abstract/Free Full Text]
  2. Hodler J, Kursunoglu-Brahme S, Snyder SJ, et al. Rotator cuff disease: assessment with MR arthrography versus standard MR imaging in 36 patients with arthroscopic confirmation. Radiology1992; 182:431 -436[Abstract/Free Full Text]
  3. Hodler J, Yu JS, Goodwin D, Haghighi P, Trudell D, Resnick D. MR arthrography of the hip: improved imaging of the acetabular labrum with histologic correlation in cadavers. AJR1995; 165:887 -891[Abstract/Free Full Text]
  4. Petersilge CA. MR arthrography for evaluation of the acetabular labrum. Skeletal Radiol 2001;30 : 423-430[CrossRef][Medline]
  5. White LM, Schweitzer ME, Weishaupt D, Kramer J, Davis A, Marks PH. Diagnosis of recurrent meniscal tears: prospective evaluation of conventional MR imaging, indirect MR arthrography, and direct MR arthrography. Radiology 2002;222 : 421-429[Abstract/Free Full Text]
  6. Sciulli RL, Boutin RD, Brown RR, et al. Evaluation of the postoperative meniscus of the knee: a study comparing conventional arthrography, conventional MR imaging, MR arthrography with iodinated contrast material, and MR arthrography with gadolinium-based contrast material. Skeletal Radiol 1999;28 : 508-514[CrossRef][Medline]
  7. Binkert CA, Zanetti M, Gerber C, Hodler J. MR arthrography of the glenohumeral joint: two concentrations of gadoteridol versus Ringer solution as the intraarticular contrast material. Radiology2001; 220:219 -224[Abstract/Free Full Text]
  8. Schulte-Altedorneburg G, Gebhard M, Wohlgemuth WA, et al. MR arthrography: pharmacology, efficacy and safety in clinical trials. Skeletal Radiol 2003;32 : 1-12[Medline]
  9. Newberg AH, Munn CS, Robbins AH. Complications of arthrography. Radiology 1985;155 : 605-606[Abstract/Free Full Text]
  10. Engel A, Hajek P, Klamer J. Magnetic resonance knee arthrography enhanced contrast by gadolinium complex in rabbits and in humans. Acta Orthop Scand 1990;61 : 1-55[Medline]
  11. Hajek PC, Sartoris DJ, Gylys-Morin V, et al. The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage. Invest Radiol 1990;25 : 179-183[Medline]
  12. Hajek PC, Sartoris DJ, Neumann CH, Resnick D. Potential contrast agents for MR arthrography: in vitro evaluation and practical observations. AJR 1987; 149:97 -104[Abstract/Free Full Text]
  13. Kopka L, Funke M, Fischer U, Keating D, Oestmann J, Grabbe E. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity. AJR 1994; 163:621 -623[Abstract/Free Full Text]
  14. Wagner SC, Schweitzer ME, Weishaupt D. Temporal behavior of intraarticular gadolinium. J Comput Assist Tomogr2001; 25:661 -670[CrossRef][Medline]
  15. Rafii M, Minkoff J. Advanced arthrography of the shoulder with CT and MR imaging. Radiol Clin North Am1998; 36:609 -633[CrossRef][Medline]
  16. Grainger AJ, Elliott JM, Campbell RS, Tirman PF, Steinbach LS, Genant HK. Direct MR arthrography: a review of current use. Clin Radiol 2000; 55:163 -176[CrossRef][Medline]
  17. Schweitzer ME, Natale P, Winalski CS, Culp R. Indirect wrist MR arthrography: the effects of passive motion versus active exercise. Skeletal Radiol 2000;29 : 10-14[CrossRef][Medline]
  18. Eng J. Sample size estimation: how many individuals should be studied? Radiology 2003;227 : 309-313[Abstract/Free Full Text]
  19. Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. Clin Pharmacokinet 2004;43 : 121-129[CrossRef][Medline]
  20. Steiner IM, Kaehler ST, Sauermann R, Rinosl H, Muller M, Joukhadar C. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. Int J Clin Pharmacol Ther2006; 44:172 -179[Medline]
  21. Hadler NM. Synovial fluids facilitate small solute diffusivity. Ann Rheum Dis 1980;39 : 580-585[Abstract/Free Full Text]
  22. Hall FM. Epinephrine-enhanced knee arthrography. Radiology 1974;111 : 215-217[Medline]
  23. Weishaupt D, Schweitzer ME, Rawool NM, et al. Indirect MR arthrography of the knee: effects of low-intensity ultrasound on the diffusion rate of intravenously administered Gd-DTPA in healthy volunteers. Invest Radiol 2001;36 : 493-499[CrossRef][Medline]
  24. Drape JL, Thelen P, Gay-Depassier P, Silbermann O, Benacerraf R. Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation. Radiology 1993;188 : 227-234[Abstract/Free Full Text]
  25. Schweitzer ME, Falk A, Berthoty D, Mitchell M, Resnick D. Knee effusion: normal distribution of fluid. AJR1992; 159:361 -363[Abstract/Free Full Text]
  26. Winalski CS, Aliabadi P, Wright RJ, Shortkroff S, Sledge CB, Weissman BN. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications. Radiology 1993;187 : 179-185[Abstract/Free Full Text]
  27. Kaura DR, Schweitzer ME, Weishaupt D, Morrison WB. Optimization of indirect arthrography of the knee by application of external heat: initial experience. J Magn Reson Imaging 2005;22 : 810-812[CrossRef][Medline]
  28. Engel A. Magnetic resonance knee arthrography: enhanced contrast by gadolinium complex in the rabbit and in humans. Acta Orthop Scand Suppl 1990; 240:1 -57[Medline]
  29. Knuesel PR, Pfirrmann CW, Noetzli HP, et al. MR arthrography of the hip: diagnostic performance of a dedicated water-excitation 3D double-echo steady-state sequence to detect cartilage lesions. AJR2004; 183:1729 -1735[Abstract/Free Full Text]
  30. Kornaat PR, Reeder SB, Koo S, et al. MR imaging of articular cartilage at 1.5T and 3.0T: comparison of SPGR and SSFP sequences. Osteoarthritis Cartilage 2005;13 : 338-344[CrossRef][Medline]
  31. Moss SG, Schweitzer ME, Jacobson JA, et al. Hip joint fluid: detection and distribution at MR imaging and US with cadaveric correlation. Radiology 1998;208 : 43-48[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
G. Andreisek, J. M. Froehlich, J. Hodler, D. Weishaupt, V. Beutler, C. W. A. Pfirrmann, C. Boesch, and D. Nanz
Direct MR Arthrography at 1.5 and 3.0 T: Signal Dependence on Gadolinium and Iodine Concentrations--Phantom Study
Radiology, June 1, 2008; 247(3): 706 - 716.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreisek, G.
Right arrow Articles by Weishaupt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreisek, G.
Right arrow Articles by Weishaupt, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS